Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

Auscultatory versus oscillometric blood pressure measurement in patients with atrial fibrillation and arterial hypertension

Authors: Aistėja Šelmytė–Besusparė, Jūratė Barysienė, Dovilė Petrikonytė, Audrius Aidietis, Germanas Marinskis, Aleksandras Laucevičius

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

The aim of our study was to investigate the reliability of automated oscillometric blood pressure (BP) monitoring in the presence and absence of atrial fibrillation (AF) in hypertensive patients.

Methods

BP was measured and compared in 71 randomly selected patients with AF and arterial hypertension diagnosis, 4 times each by auscultatory and oscillometric (Microlife BP A6 PC with AF detection system) methods.

Results

Study included 71 patients: 36 males (mean age 67.4 years) and 35 females (70.2 years). At the time of BP measuring procedure, 36 patients were in sinus rhythm (SR) and 35 in AF. In SR patients mean systolic blood pressure (SBP) was 132 ± 17.9 mmHg with auscultatory method (AM), 137.4 ± 19.4 mmHg with oscillometric method (OM); mean diastolic BP was 77.1 ± 10.9 mmHg (AM), 78.5 ± 12.2 mmHg (OM), in AF patients mean SBP was 127.5 ± 15.1 mmHg (AM), 133.6 ± 17.4 mmHg (OM); mean diastolic BP was 81.4 ± 9.9 mmHg (AM), 83.5 ± 11.8 mmHg (OM), p = 0.037. The averages of differences for SBP and DBP in sinus rhythm group were (−5.3 mmHg (95% limits of agreement −27.2 – 16.6)) and (−1.4 mmHg (95% limits of agreement −12.8 – 10.0)), respectively. In patients with AF the averages of differences for SBP and DBP were (−6.1 mmHg (95% limits of agreement −23.9 – 11.7)) and (−2.1 mmHg (95% limits of agreement −12.9 – 8.7)), respectively.

Conclusions

The oscillometric device validated for patients with AF on average gives 5.3 mmHg higher systolic BP values for patients with SR and 6.3 mmHg higher BP values for patients with AF. However, the limits of agreement between two methods reveal wide range of random error rates which is a questionable topic in clinical practice, as it could possibly affect the treatment of arterial hypertension in patients with AF.
Appendix
Available only for authorised users
Literature
1.
Scanavacca M, Darrieux F. Factors in deciding between novel and traditional oral anticoagulants to prevent embolism in atrial fibrillation patients. Arq Bras Cardiol. 2016;106(1):1–3.PubMedPubMedCentral
2.
Miller JD, Aronis KN, Chrispin J, Patil KD, Marine JE, Martin SS, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol. 2015;66(25):2899–906.CrossRefPubMed
3.
Gürdoğan M, Ari H, Tenekecioğlu E, Ari S, Bozat T, Koca V, et al. Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients. Arq Bras Cardiol. 2016;(AHEAD).
4.
Authors/Task Force Members, Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation * developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–47.CrossRef
5.
Vlachos K, Letsas KP, Korantzopoulos P, Liu T, Georgopoulos S, Bakalakos A, et al. Prediction of atrial fibrillation development and progression: current perspectives. World J Cardiol. 2016;8(3):267.CrossRefPubMedPubMedCentral
6.
Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol. 2005;45(5):705–11.CrossRefPubMed
7.
Kirchhof P, Lip GYH, Van Gelder IC, Bax J, Hylek E, Kaab S, et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd atrial fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2012;14(1):8–27.CrossRefPubMed
8.
Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, et al. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the working group ‘hypertension arrhythmias and thrombosis’ of the European Society of Hypertension. J Hypertens. 2012;30(2):239–52.CrossRefPubMed
9.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.CrossRefPubMed
10.
Hänninen M-RA, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home study. J Hypertens. 2012;30(4):705–12.CrossRefPubMed
11.
Jani B, Bulpitt CJ, Rajkumar C. Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens. 2006;20(7):543–5.CrossRefPubMed
12.
Pagonas N, Schmidt S, Eysel J, Compton F, Hoffmann C, Seibert F, et al. Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension. 2013;62(3):579–84.CrossRefPubMed
13.
O’Brien E, Asmar R, Beilin L, Imai Y, Mallion J-M, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:301–6.
14.
Maselli M, Giantin V, Corrado D, Franchin A, Attanasio F, Pengo V, et al. Reliability of oscillometric blood pressure monitoring in atrial fibrillation patients admitted for electric cardioversion. J Clin Hypertens Greenwich Conn. 2015;17(7):558–64.CrossRef
15.
O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322(7285):531–6.CrossRefPubMedPubMedCentral
16.
Verberk WJ, Omboni S, Kollias A, Stergiou GS. Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations. Int J Cardiol. 2016;203:465–73.CrossRefPubMed
17.
Lip GYH, Zarifis J, Beevers M, Beevers DG. Ambulatory blood pressure monitoring in atrial fibrillation. Am J Cardiol. 1996;78(3):350–3.CrossRefPubMed
18.
Stergiou GS, Kollias A, Destounis A, Tzamouranis D. Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis. J Hypertens. 2012;30(11):2074–82.CrossRefPubMed
19.
American National Standards Institute. Noninvasive sphygmomanometers. Part 2: Clinical validation of automated measurement type. ANSI/AAMI/ISO. 2009;81060(2):1–13.
20.
Bilo G, Zorzi C, Ochoa Munera JE, Torlasco C, Giuli V, Parati G. Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2015;20(5):291–4.CrossRefPubMedPubMedCentral
21.
Hurley V, Ireson R, Fletcher K, Lip GY, Hobbs FR, Mant J. A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the birmingham atrial fibrillation in the aged (BAFTA) randomised controlled trial. Int J Cardiol. 2007;117(2):152–6.CrossRefPubMed
22.
Giavarina D. Understanding bland altman analysis. Biochem Med. 2015;25(2):141–51.CrossRef
23.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud. 2010;47(8):931–6.CrossRef
24.
Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men a 35-year follow-up study. Hypertension. 2012;59(2):198–204.CrossRefPubMed
25.
Badheka AO, Patel NJ, Grover PM, Shah N, Patel N, Singh V, et al. Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM trial). Am J Cardiol. 2014;114(5):727–36.CrossRefPubMed
26.
Group TSR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef
27.
Pflederer MC, Estacio RO, Krantz MJ. Is 60 the new 80 in hypertension? J Gen Intern Med. 2016;31(8):958–60.CrossRefPubMed
Metadata
Title
Auscultatory versus oscillometric blood pressure measurement in patients with atrial fibrillation and arterial hypertension
Authors
Aistėja Šelmytė–Besusparė
Jūratė Barysienė
Dovilė Petrikonytė
Audrius Aidietis
Germanas Marinskis
Aleksandras Laucevičius
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0521-6

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue

Research article

Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study

Research article

The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR

Research article

Effectiveness of a PRECEDE-based education intervention on quality of life in elderly patients with chronic heart failure

Research article

Understanding heart failure; explaining telehealth – a hermeneutic systematic review

Research article

Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Research article

Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits